@writer Agreed.
Alot of the biotechs i owned and believed in back in the 2010s either went into administration or relisted as lithium or other mining companies. Many of the "Internet of things" companies also went belly up. Ideas are a dime a dozen, taking them from concept to delivery is usually a marathon and few find a way of achieving it. Possibly the single distinguishing feature that got us here is the board's refusal to pander to shareholder criticism, it shows the sort of drive and uncompromising determination that is required in successful enterprise. A more thoughtful or generous approach (some would say transparent or frugal) would possibly have ended in failure to deliver.It was always about creating a disruptive blockbuster product, which we now know they have succeeded in doing.Now we just need the revenue to start flowing and the more cautious investors will finally join the party
Add to My Watchlist
What is My Watchlist?
